Family Care Hospitals Ltd (FAMILYCARE) — shareholding pattern, promoter holding, financials and share price
About Family Care Hospitals Ltd (FAMILYCARE)
Family Care Hospitals Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as FAMILYCARE and on the BSE under scrip code 516110. Its ISIN is INE146N01016.
Incorporated in 1994, Family Care Hospitals Ltd is in the business of providing Healthcare Services. [1]
Family Care Hospitals Limited is actively engaged in healthcare services, with its origins dating back to 1982 when it was a partnership firm under the name Pharma Offset Limited.
The company has evolved through several name changes as it expanded and diversified its operations, finally becoming Family Care Hospitals Limited in 2022, focusing on healthcare services.
Listed peers in Healthcare Service Provider: Transgene Biotek Ltd, Nidan Laboratories & Healthcare Ltd, Dhanvantri Jeevan Rekha Ltd, Clinitech Laboratory Ltd, Looks Health Services Ltd, Dr Lalchandani Labs Ltd.
Valuation & Returns
10 Jul 2026At ₹2.96 a share on 10 Jul 2026, Family Care Hospitals Ltd (FAMILYCARE) was valued at a price-to-book of 1.19x on a book value of ₹2.49 per share as of Mar 2025. Solomo computes return on equity of -64.56% and return on capital employed of -49.32% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- Industry P/E
- 61.73x
- P/B
- 1.19x
- EPS (TTM)
- ₹-1.61
- Book value / share
- ₹2.49
- ROE
- -64.56%
- ROCE
- -49.32%
- ROA
- -18.85%
- Debt / equity
- 0.25x
- Dividend yield
- 0%
- 52-week range
- ₹2.55 – ₹5.83
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Family Care Hospitals Ltd (FAMILYCARE) reported revenue of ₹0.21 crore, net profit of ₹-8.68 crore and earnings per share of ₹-1.61. That compares with revenue of ₹7.9 crore and net profit of ₹-44.15 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.06 crore and net profit ₹-2.42 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 42.07 | 42.04 | 40.01 | 7.9 | 0.21 |
| Net profit (₹ cr) | 5.2 | 5.26 | 12.55 | -44.15 | -8.68 |
| EPS (₹) | 0.71 | 0.97 | 2.32 | -8.17 | -1.61 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 24.88% | -9.81% | -42.72% | -80.25% |
| Profit growth | - | - | - | -451.79% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 17.47% of Family Care Hospitals Ltd (FAMILYCARE) (down 1.07 pp QoQ) and domestic institutional investors (DII) hold 0.09%. Promoters have pledged 65.5% of their holding. Market capitalisation was ₹16 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: LAAVNYA . 1.33%, BALA VENKATA REDDY UMMALAREDDY 1.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 17.47% | 65.5% | - | 0.09% | 82.53% |
| Mar 2026 | 18.54% | 61.7% | - | 0.09% | 81.46% |
| Dec 2025 | 18.54% | 61.7% | - | 0.09% | 81.46% |
| Sep 2025 | 18.54% | 61.7% | - | 0.09% | 81.46% |
| Jun 2025 | 18.54% | 61.7% | - | 0.09% | 81.46% |
| Mar 2025 | 18.54% | 61.7% | - | 0.09% | 81.46% |
| Dec 2024 | 18.54% | 61.7% | - | 0.09% | 81.46% |
| Sep 2024 | 18.54% | 61.7% | - | 0.09% | 81.46% |